CV
Cavallo Ventures
Corporate VCActiveCavallo Ventures is the venture capital arm of Wilbur-Ellis, a privately owned family business approaching its centennial anniversary
15
Investments
1
Exits
—
AUM
6.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Cavallo Ventures.
Investment Thesis & Strategy
Cavallo Ventures, as the CVC arm of Wilbur-Ellis, invests in various stages of companies, likely focusing on those that align with Wilbur-Ellis's core business and strategic interests. They seek companies that can provide strategic value and potential synergies with the parent company.
Investment Activity
Deals per year over the last 5 years
3
20174
20180
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 15 companies
I
Inari
Biotech · Series C+, 2021
P
Pairwise
Biotech · Series A, 2018
P
Pivot Bio
Biotech · Series B, 2018
P
Provivi
Biotech · Series B, 2018
A
Apeel Sciences
Cleantech · Series C+, 2018
I
Indigo Agriculture
Biotech · Series C+, 2017
T
Trace Genomics
Biotech · Series A, 2017
F
Farmers Business Network
Fintech · Series C+, 2017
Frequently Asked Questions
Cavallo Ventures focuses on Series A, Series B stage investments.
Related Investors
Salesforce Ventures
San Francisco, United States · 463 deals
Cisco Investments
San Francisco, United States · 123 deals
Coinbase Ventures
San Francisco, United States · 39 deals
Alexandria Venture
San Francisco, United States · 39 deals
Workday Ventures
San Francisco, United States · 37 deals
Slack
San Francisco, United States · 29 deals